291 related articles for article (PubMed ID: 27048775)
21. Effect of ester to amide or N-methylamide substitution on bacterial membrane depolarization and antibacterial activity of novel cyclic lipopeptides.
Bionda N; Fleeman RM; Shaw LN; Cudic P
ChemMedChem; 2013 Aug; 8(8):1394-402. PubMed ID: 23780744
[TBL] [Abstract][Full Text] [Related]
22. Design and Solution-Phase Synthesis of Membrane-Targeting Lipopeptides with Selective Antibacterial Activity.
Konai MM; Adhikary U; Haldar J
Chemistry; 2017 Sep; 23(52):12853-12860. PubMed ID: 28718982
[TBL] [Abstract][Full Text] [Related]
23. Cyclic lipopeptides as antibacterial agents - potent antibiotic activity mediated by intriguing mode of actions.
Schneider T; Müller A; Miess H; Gross H
Int J Med Microbiol; 2014 Jan; 304(1):37-43. PubMed ID: 24119568
[TBL] [Abstract][Full Text] [Related]
24. Structure-activity relationships in ultrashort cationic lipopeptides: the effects of amino acid ring constraint on antibacterial activity.
Domalaon R; Yang X; O'Neil J; Zhanel GG; Mookherjee N; Schweizer F
Amino Acids; 2014 Nov; 46(11):2517-30. PubMed ID: 25069750
[TBL] [Abstract][Full Text] [Related]
25. A Biosurfactant-Inspired Heptapeptide with Improved Specificity to Kill MRSA.
Liu Y; Ding S; Dietrich R; Märtlbauer E; Zhu K
Angew Chem Int Ed Engl; 2017 Feb; 56(6):1486-1490. PubMed ID: 28106348
[TBL] [Abstract][Full Text] [Related]
26. Physicochemical and Biological Characterization of Novel Membrane-Active Cationic Lipopeptides with Antimicrobial Properties.
Juhaniewicz-Dębińska J; Lasek R; Tymecka D; Burdach K; Bartosik D; Sęk S
Langmuir; 2020 Nov; 36(43):12900-12910. PubMed ID: 33085895
[TBL] [Abstract][Full Text] [Related]
27. Antibacterial efficacy and membrane mechanism of action of the
Decker T; Rautenbach M; Khan S; Khan W
Microbiol Spectr; 2024 Jul; 12(7):e0295223. PubMed ID: 38842361
[TBL] [Abstract][Full Text] [Related]
28. A bioinspired peptide scaffold with high antibiotic activity and low in vivo toxicity.
Rabanal F; Grau-Campistany A; Vila-Farrés X; Gonzalez-Linares J; Borràs M; Vila J; Manresa A; Cajal Y
Sci Rep; 2015 May; 5():10558. PubMed ID: 26024044
[TBL] [Abstract][Full Text] [Related]
29. Characterization of antimicrobial and hemolytic properties of short synthetic cationic lipopeptides based on QSAR/QSTR approach.
Greber KE; Ciura K; Belka M; Kawczak P; Nowakowska J; Bączek T; Sawicki W
Amino Acids; 2018 Apr; 50(3-4):479-485. PubMed ID: 29264738
[TBL] [Abstract][Full Text] [Related]
30. In Silico Discovery of Novel Ligands for Antimicrobial Lipopeptides for Computer-Aided Drug Design.
Jujjavarapu SE; Dhagat S
Probiotics Antimicrob Proteins; 2018 Jun; 10(2):129-141. PubMed ID: 29218506
[TBL] [Abstract][Full Text] [Related]
31. Antibacterial Cyclic Lipopeptide Enamidonins with an Enamide-Linked Acyl Chain from a Streptomyces Species.
Son S; Ko SK; Kim SM; Kim E; Kim GS; Lee B; Ryoo IJ; Kim WG; Lee JS; Hong YS; Jang JH; Ahn JS
J Nat Prod; 2018 Nov; 81(11):2462-2469. PubMed ID: 30339391
[TBL] [Abstract][Full Text] [Related]
32. Antibacterial and biofilm disruptive nonribosomal lipopeptides from Streptomyces parvulus against multidrug-resistant bacterial infections.
Kadaikunnan S; Vijayaragavan P; Rathi MA; Balamuralikrishnan B; Alharbi NS; Gopalakrishnan VK; Purushothaman S; Sivanesan R
J Infect Public Health; 2024 Mar; 17(3):450-456. PubMed ID: 38262082
[TBL] [Abstract][Full Text] [Related]
33. Effect of self-assembly on antimicrobial activity of double-chain short cationic lipopeptides.
Stachurski O; Neubauer D; Małuch I; Wyrzykowski D; Bauer M; Bartoszewska S; Kamysz W; Sikorska E
Bioorg Med Chem; 2019 Dec; 27(23):115129. PubMed ID: 31668583
[TBL] [Abstract][Full Text] [Related]
34. Design and membrane-disruption mechanism of charge-enriched AMPs exhibiting cell selectivity, high-salt resistance, and anti-biofilm properties.
Han HM; Gopal R; Park Y
Amino Acids; 2016 Feb; 48(2):505-22. PubMed ID: 26450121
[TBL] [Abstract][Full Text] [Related]
35. De novo design of short antimicrobial lipopeptides.
Posada V; Espejo BF; Orduz S
An Acad Bras Cienc; 2021; 93(suppl 4):e20210362. PubMed ID: 34817038
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the in vitro activity of novel lipoglycopeptide antibiotics.
Arhin FF; Belley A; McKay GA; Moeck G
Curr Protoc Microbiol; 2010 Feb; Chapter 17():Unit17.1. PubMed ID: 20131224
[TBL] [Abstract][Full Text] [Related]
37. Infection-activated lipopeptide nanotherapeutics with adaptable geometrical morphology for in vivo bacterial ablation.
Yu QH; Huang R; Wu KY; Han XL; Cheng YJ; Liu WL; Zhang AQ; Qin SY
Acta Biomater; 2022 Dec; 154():359-373. PubMed ID: 36191775
[TBL] [Abstract][Full Text] [Related]
38. Antibacterial activity of ultrashort cationic lipo-beta-peptides.
Serrano GN; Zhanel GG; Schweizer F
Antimicrob Agents Chemother; 2009 May; 53(5):2215-7. PubMed ID: 19237652
[TBL] [Abstract][Full Text] [Related]
39. Synthetic antimicrobial peptidomimetics with therapeutic potential.
Haug BE; Stensen W; Kalaaji M; Rekdal Ø; Svendsen JS
J Med Chem; 2008 Jul; 51(14):4306-14. PubMed ID: 18570363
[TBL] [Abstract][Full Text] [Related]
40. The Activity of Small Urea-γ-AApeptides Toward Gram-Positive Bacteria.
Su M; Shi Y; Wang M; Gao R; Wu J; Xu H; Xi C; Cai J
ChemMedChem; 2019 Dec; 14(23):1963-1967. PubMed ID: 31677239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
